Professor John Radford 

2011

• Barrington, S., Mackewn, J., Schleyer, P., Marsden, P., Mikhaeel, N., Qian, W., Mouncey, P., Patrick, P., Popova, B., Johnson, P., Radford, J. & O'Doherty, M (2011). Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma. Ann Oncol, 22(3), 739-45. eScholarID:144771 | PMID:20813876 | DOI:10.1093/annonc/mdq428
• Greystoke, A., O'Connor, J., Linton, K., Taylor, M., Cummings, J., Ward, T., Maders, F., Hughes, A., Ranson, M., Illidge, T., Radford, J. & Dive, C (2011). Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma. Br J Cancer, 104(4), 719-25. eScholarID:144772 | PMID:21245866 | DOI:10.1038/sj.bjc.6606082
• Naidoo, K., Clay, V., Hoyland, J., Swindell, R., Linton, K., Illidge, T., Radford, J. & Byers, R (2011). YY1 expression predicts favourable outcome in follicular lymphoma. J Clin Pathol, 64(2), 125-9. eScholarID:117658 | PMID:21109702 | DOI:10.1136/jcp.2010.078188
• Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, Hoskin PJ, Lister TA, Radford JA, Rohatiner AZ, Linch DC. (2011). Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study. J Clin Oncol, 29(31), 4096-4104. eScholarID:141960 | DOI:10.1200/JCO.2011.34.8268

2010

• Agathocleous, A., Rohatiner, A., Rule, S., Hunter, H., Kerr, J., Neeson, S., Matthews, J., Strauss, S., Montoto, S., Johnson, P., Radford, J. & Lister, A (2010). Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemia. Br J Haematol, 151(4), 346-53. eScholarID:117661 | PMID:20880120 | DOI:10.1111/j.1365-2141.2010.08340.x
• Barrington, S., Qian, W., Somer, E., Franceschetto, A., Bagni, B., Brun, E., Almquist, H., Loft, A., Højgaard, L., Federico, M., Gallamini, A., Smith, P., Johnson, P., Radford, J. & O'Doherty, M (2010). Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging, 37(10), 1824-33. eScholarID:117660 | PMID:20505930 | DOI:10.1007/s00259-010-1490-5
• d'Amore, F., Radford, J., Relander, T., Jerkeman, M., Tilly, H., Osterborg, A., Morschhauser, F., Gramatzki, M., Dreyling, M., Bang, B. & Hagberg, H (2010). Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma. Br J Haematol, 150(5), 565-73. eScholarID:117659 | PMID:20629661 | DOI:10.1111/j.1365-2141.2010.08298.x
• Johnson, P., Sydes, M., Hancock, B., Cullen, M., Radford, J. & Stenning, S (2010). Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma: survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519). J Clin Oncol, 28(20), 3352-9. eScholarID:117655 | PMID:20498402 | DOI:10.1200/JCO.2009.26.0323

2009

• Linton K, Hey YY, Dibben SSM, Miller CCJ, Freemont AJ, Radford JA, Pepper SS. (2009). Methods comparison for high-resolution transcriptional analysis of archival material on Affymetrix Plus 2.0 and Exon 1.0 microarrays. Biotechniques, 47( 1), eScholarID:1d20623 | DOI:10.2144/000113169

2008

• Byers RJ, Sakhinia E, Joseph P, Glennie C, Hoyland JA, Menasce L, Radford JA, Illidge TM. (2008). Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling. Blood, 111( 9), eScholarID:1d18683 | DOI:10.1182/blood-2007-10-115915
• Hagenbeek, A., Gadeberg, O., Johnson, P., Pedersen, L., Walewski, J., Hellmann, A., Link, B., Robak, T., Wojtukiewicz, M., Pfreundschuh, M., Kneba, M., Engert, A., Sonneveld, P., Flensburg, M., Petersen, J., Losic, N. & Radford, J (2008). First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial. Blood, 111(12), 5486-95. eScholarID:117662 | PMID:18390837 | DOI:10.1182/blood-2007-10-117671

2007

• Sakhinia E, Glennie C, Hoyland JA, Menasce L, Brady G, Miller CCJ, Radford JA, Byers RJ. (2007). Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling. Blood, 109( 9), 3922-8. eScholarID:1d16090

2006

• Betticher, D, Martinelli, G, Radford, JA, Kaufmann, M, Dyer, M, Kaiser, U, Aulitzky, W, Beck, J, von Rohr, A, Kovascovics, T, Cogliatti, S, Cina, S, Maibach, R, Cerny, T, Linch, D. (2006). Sequential high dose chemotherapy as initial treatment for aggressive sub-types of non-Hodgkin lymphoma: results of the international randomized phase III trial (MISTRAL). Ann Oncol, 17( 10), 1546-52. eScholarID:1d30480
• Chanudet, E, Zhou, Y, Bacon, C, Wotherspoon, A, Müller-Hermelink, H, Adam, P, Dong, H, de Jong, D, Li, Y, Wei, R, Gong, X, Wu, Q, Ranaldi, R, Goteri, G, Pileri, S, Ye, H, Hamoudi, R, Liu, H, Radford, JA, Du, M. (2006). Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J Pathol, 209( 3), 344-51. eScholarID:1d30460
• Franklin, J, Pluetschow, A, Paus, M, Specht, L, Anselmo, A, Aviles, A, Biti, G, Bogatyreva, T, Bonadonna, G, Brillant, C, Cavalieri, E, Diehl, V, Eghbali, H, Fermé, C, Henry-Amar, M, Hoppe, R, Howard, S, Meyer, R, Niedzwiecki, D, Pavlovsky, S, Radford, JA, Raemaekers, J, Ryder, D, Schiller, P, Shakhtarina, S, Valagussa, P, Wilimas, J, Yahalom, J. (2006). Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. Ann Oncol, 17( 12), 1749-60. eScholarID:1d30459
• Strauss, S, Maharaj, L, Hoare, S, Johnson, P, Radford, JA, Vinnecombe, S, Millard, L, Rohatiner, A, Boral, A, Trehu, E, Schenkein, D, Balkwill, F, Joel, S, Lister, T. (2006). Bortezomib Therapy in Patients With Relapsed or Refractory Lymphoma: Potential Correlation of In Vitro Sensitivity and Tumor Necrosis Factor Alpha Response With Clinical Activity. J Clin Oncol, eScholarID:1d31489

2005

• Cheadle EJ, Gilham DE, Thistlethwaite FC, Radford JA, Hawkins RE. (2005). Killing of non-Hodgkin lymphoma cells by autologous CD19 engineered T cells. Br J Haematol, 129( 3), 322-32. eScholarID:1d29482
• Johnson, P, Radford, JA, Cullen, M, Sydes, M, Walewski, J, Jack, A, MacLennan, K, Stenning, S, Clawson, S, Smith, P, Ryder, D, Hancock, B. (2005). Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519). J Clin Oncol, 23( 36), 9208-18. eScholarID:1d12945 | DOI:10.1200/JCO.2005.03.2151
• Kaminski M, Radford JA, Gregory S, Leonard J, Knox S, Kroll S, Wahl R. (2005). Re-treatment with Tositumomab and Iodine I 131 Tositumomab in patients with non-Hodgkin lymphoma who had previously responded to Tositumomab and Iodine I 131 Tositumomab. J Clin Oncol, 23( 31), eScholarID:1d30740
• Ye, H, Gong, L, Liu, H, Hamoudi, R, Shirali, S, Ho, L, Chott, A, Streubel, B, Siebert, R, Gesk, S, Martin-Subero, J, Radford, JA, Banerjee, S, Nicholson, A, Ranaldi, R, Remstein, E, Gao, Z, Zheng, J, Isaacson, P, Dogan, A, Du, M. (2005). MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression. J Pathol, 205( 3), 293-301. eScholarID:1d30741

2004

• Davies, A, Rohatiner, A, Howell, S, Britton, K, Owens, S, Micallef, I, Deakin, D, Carrington, B, Lawrance, J, Vinnicombe, S, Mather, S, Clayton, J, Foley, R, Jan, H, Kroll, S, Harris, M, Amess, J, Norton, A, Lister, T, Radford, JA. (2004). Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma. J Clin Oncol, 22( 8), 1469-79. eScholarID:1d9370 | DOI:10.1200/JCO.2004.06.055
• Eyden B, Radford JA, Shalet SM, Thomas N, Brison DR, Lieberman B. (2004). Ultrastructural preservation of ovarian cortical tissue cryopreserved in dimethylsulfoxide for subsequent transplantation into young female cancer patients. Ultrastructural Pathology, 28(4), eScholarID:1d10801
• Harris M, Radford JA, Deakin D, James R, Swindell R, Cowan R. (2004). Limited field radiotherapy for early stage, infra-diaphragmatic Hodgkin's lymphoma. Clin Oncol (R Coll Radiol), 16( 1), 53-7. eScholarID:1d29140

2003

• Radford JA. (2003). Restoration of fertility after treatment for cancer. Hormone Research, eScholarID:1d33688
• Shears DJ, V Endris, D A Gokhale, S P Dearden, Radford JA, G A Rappold, Taylor GM. (2003). Pseudoautosomal linkage of familial Hodgin's lymphoma: molecular analysis of a unique family with Leri-Weill Dyschondrosteosis and Hodgkin's Lymphoma. British Journal of Haematology, 121(2), 375-380. eScholarID:1d5853

2002

• Blackhall FH, Atkinson AD, Maaya MB, Ryder WD, Horne G, Brison DR, Brian Lieberman, Radford JA. (2002). Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's disease. Br J Cancer, 87, eScholarID:1d3143
• Howell S, Grey M, Chang JG, Morgenstern G, Cowan RA, Deakin DP, Radford JA. (2002). The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre. Br J Haematol, 119, 408-11. eScholarID:1d3142
• Radford, JA, Rohatiner AZS, Ryder WBJ, Deakin, DP, Barbui T, Lucie NP, Rossi A, Dunlop DJ, Cowan, RA, Wilkinson, PM, Gupta RK, James RD, Shamash J, Chang, JG, Crowther D, Lister TA. (2002). ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease. Journal of Clinical Oncology, 20, 2988-2994. eScholarID:1d3140

2001

• Brook, P., Radford, J., Shalet, S., Joyce, A. & Gosden, R (2001). Isolation of germ cells from human testicular tissue for low temperature storage and autotransplantation. Fertil Steril, 75(2), 269-74. eScholarID:144817 | PMID:11172826
• Coulson, C., Kershaw, H., Radford, J. & Larcher, V (2001). Semen collection from young cancer patients. Hum Fertil (Camb), 4(3), 131-4. eScholarID:144769 | PMID:11591268
• Horne G, Atkinson A, Brison DR, Radford JA, Yin JA, Edi-Osagie EC, Pease EH, Lieberman BB. (2001). Achieving pregnancy against the odds: successful implantation of frozen-thawed embryos generated by ICSI using spermatozoa banked prior to chemo/radiotherapy for Hodgkin's disease and acute leukaemia. Hum Reprod, 16(1), eScholarID:1d7515
• Radford, JA, Lieberman, B, Brison, D, Smith, A, Critchlow, J, Russell, S, Watson, A, Clayton, J, Harris, M, Gosden, R, Shalet, S. (2001). Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma. Lancet, 357( 9263), 1172-5. eScholarID:1d9371 | DOI:10.1016/S0140-6736(00)04335-X

2000

• Nielsen, O., Judson, I., van Hoesel, Q., le Cesne, A., Keizer, H., Blay, J., van Oosterom, A., Radford, J., Svancárová, L., Krzemienlecki, K., Hermans, C., van Glabbeke, M., Oosterhuis, J. & Verweij, J (2000). Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer, 36(1), 61-7. eScholarID:144767 | PMID:10741296

1999

• Sengupta PS Slade RJ Eardley A, Jayson G-, Radford JA. (1999). An audit of primary surgical treatment for women with ovarian cancer referred to a cancer centre. Br J Cancer, 80, eScholarID:1d2178
• Shipp, M., Abeloff, M., Antman, K., Carroll, G., Hagenbeek, A., Loeffler, M., Montserrat, E., Radford, J., Salles, G., Schmitz, N., Symann, M., Armitage, J., Philip, T. & Coiffier, B (1999). International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury. J Clin Oncol, 17(1), 423-9. eScholarID:144766 | PMID:10458261
• Taylor GM, Gokhale DA, Gokhale DA, Crowther D, Crowther D, Woll PJ, Harris M, Ryder D, Ayres M, Radford, JA. (1999). Further investigation of the role of HLA-DPB 1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes. British Journal of Cancer, 50, 1405-1411. eScholarID:1d3097

1998

• Adams M A'Hern RP Calvert AH Carmichael J, Jayson G-, Kaye SB Ledermann JA Osborne RJ Perren TJ, Poole CJ Rustin GJ Slevin ML Smyth JF Thomas H Wilkinson PM, Radford JA, Clark PI Coleman RE Earl HM Gallagher CJ, Ganesan TS Gore ME Graham JD Harper PG. (1998). Chemotherapy for ovarian cancer--a consensus statement on standard practice. Br J Cancer, 78, eScholarID:1d2180
• Coiffier, B., Haioun, C., Ketterer, N., Engert, A., Tilly, H., Ma, D., Johnson, P., Lister, A., Feuring-Buske, M., Radford, J., Capdeville, R., Diehl, V. & Reyes, F (1998). Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood, 92(6), 1927-32. eScholarID:144702 | PMID:9731049
• Lee, S., Radford, J., Dobson, L., Huq, T., Ryder, W., Pettengell, R., Morgenstern, G., Scarffe, J. & Crowther, D (1998). Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost. Br J Cancer, 77(8), 1294-9. eScholarID:144697 | PMID:9579836
• Weaver, A., Chang, J., Wrigley, E., de Wynter, E., Woll, P., Lind, M., Jenkins, B., Gill, C., Wilkinson, P., Pettengell, R., Radford, J., Collins, C., Dexter, T., Testa, N. & Crowther, D (1998). Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer. J Clin Oncol, 16(8), 2601-12. eScholarID:144700 | PMID:9704709

1997

• Dobson, M., Carrington, B., Radford, J., Buckley, C. & Crowther, D (1997). The role of computed tomography in the management of ovarian tumours of borderline malignancy. Clin Radiol, 52(4), 280-3. eScholarID:144705 | PMID:9112945
• Lee, S., Radford, J., Ryder, W., Collins, C., Deakin, D. & Crowther, D (1997). Prognostic factors for disease progression in advanced Hodgkin's disease: an analysis of patients aged under 60 years showing no progression in the first 6 months after starting primary chemotherapy. Br J Cancer, 75(1), 110-5. eScholarID:144698 | PMID:9000607
• Radford, J., Eardley, A., Woodman, C. & Crowther, D (1997). Follow up policy after treatment for Hodgkin's disease: too many clinic visits and routine tests? A review of hospital records. BMJ, 314(7077), 343-6. eScholarID:144685 | PMID:9040326

1996

• Betticher, D., Zucca, E., von Rohr, A., Egger, T., Radford, J., Ambrosetti, A., Bürki, K., Rufener, B., Schmitz, S. & Cerny, T (1996). 2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma. Ann Oncol, 7(8), 793-9. eScholarID:144681 | PMID:8922192
• Pettengell, R., Radford, J., Morgenstern, G., Scarffe, J., Harris, M., Woll, P., Deakin, D., Ryder, D., Wilkinson, P. & Crowther, D (1996). Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. J Clin Oncol, 14(2), 586-92. eScholarID:144703 | PMID:8636775
• Wrigley, E., Weaver, A., Jayson, G., Ranson, M., Renninson, J., Prendiville, J., Dobson, M., Collins, C., Swindell, R., Buckley, C., Radford, J. & Crowther, D (1996). A randomised trial investigating the dose intensity of primary chemotherapy in patients with ovarian carcinoma: a comparison of chemotherapy given every four weeks with the same chemotherapy given at three week intervals. Ann Oncol, 7(7), 705-11. eScholarID:144684 | PMID:8905028

1995

• Clark, S., Radford, J., Crowther, D., Swindell, R. & Shalet, S (1995). Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen. J Clin Oncol, 13(1), 134-9. eScholarID:144689 | PMID:7799013
• de Campos, E., Radford, J., Steward, W., Milroy, R., Dougal, M., Swindell, R., Testa, N. & Thatcher, N (1995). Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer. J Clin Oncol, 13(7), 1623-31. eScholarID:144765 | PMID:7602351
• Radford, J., Crowther, D., Rohatiner, A., Ryder, W., Gupta, R., Oza, A., Deakin, D., Arnott, S., Wilkinson, P. & James, R (1995). Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease. J Clin Oncol, 13(9), 2379-85. eScholarID:144699 | PMID:7666097
• Scheid, C., Pettengell, R., Ghielmini, M., Radford, J., Morgenstern, G., Stern, P. & Crowther, D (1995). Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma. Bone Marrow Transplant, 15(6), 901-6. eScholarID:144712 | PMID:7581089
• Wong-You-Cheong, J. & Radford, J (1995). Case report: enlargement of a mediastinal mass during treatment for Hodgkin's disease may be due to accumulation of fluid within thymic cysts. Clin Radiol, 50(1), 61-2. eScholarID:144686 | PMID:7834979

1994

• de Campos, E., Menasce, L., Radford, J., Harris, M. & Thatcher, N (1994). Metastatic carcinoma of uncertain primary site: a retrospective review of 57 patients treated with vincristine, doxorubicin, cyclophosphamide (VAC) or VAC alternating with cisplatin and etoposide (VAC/PE). Cancer, 73(2), 470-5. eScholarID:144763 | PMID:8293415
• Radford, J., Clark, S., Crowther, D. & Shalet, S (1994). Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and non-Hodgkin's lymphoma. Br J Cancer, 69(2), 379-81. eScholarID:144691 | PMID:7507693
• Radford, J., Whelan, J., Rohatiner, A., Deakin, D., Harris, M., Stansfeld, A., Swindell, R., Wilkinson, P., James, R. & Lister, T (1994). Weekly VAPEC-B chemotherapy for high grade non-Hodgkin's lymphoma: results of treatment in 184 patients. Ann Oncol, 5(2), 147-51. eScholarID:144713 | PMID:7514433

1993

• Anderson, H., Hopwood, P., Prendiville, J., Radford, J., Thatcher, N. & Ashcroft, L (1993). A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer. Br J Cancer, 67(6), 1385-90. eScholarID:144682 | PMID:8390287
• Pettengell, R., Morgenstern, G., Woll, P., Chang, J., Rowlands, M., Young, R., Radford, J., Scarffe, J., Testa, N. & Crowther, D (1993). Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood, 82(12), 3770-7. eScholarID:144694 | PMID:7505124
• Radford, J., Morgenstern, G. & Crowther, D (1993). The management of Hodgkin's disease. Ann Oncol, 4(5), 417-21. eScholarID:144707 | PMID:7688981
• Van Hoef, M., Radford, J., Jones, A., Smith, I., Earl, H., Woll, P. & Thatcher, N (1993). Urinary-derived monocyte-colony stimulating factor (P-100) following treatment with carboplatin and etoposide in small cell lung cancer (SCLC). Ann Oncol, 4(10), 877-81. eScholarID:144711 | PMID:8117608

1992

• Dodwell, D., de Campos, E. & Radford, J (1992). Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it? Drugs, 44(1), 1-8. eScholarID:144688 | PMID:1379906
• Gurney, H., Anderson, H., Radford, J., Potter, M., Swindell, R., Steward, W., Kamthan, A., Chang, J., Weiner, J. & Thatcher, N (1992). Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor. Eur J Cancer, 28(1), 105-12. eScholarID:144760 | PMID:1314626
• Hrubisko, M., Mc Gown, A., Prendiville, J., Radford, J., Thatcher, N. & Fox, B (1992). Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump. Cancer Chemother Pharmacol, 29(3), 252-5. eScholarID:144704 | PMID:1733559
• Pettengell, R., Gurney, H., Radford, J., Deakin, D., James, R., Wilkinson, P., Kane, K., Bentley, J. & Crowther, D (1992). Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood, 80(6), 1430-6. eScholarID:144690 | PMID:1381626
• Radford, J., Ryder, W., Dodwell, D., Anderson, H. & Thatcher, N (1992). Predicting septic complications of chemotherapy: an analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis. Eur J Cancer, 29A(1), 81-6. eScholarID:144696 | PMID:1332739

1991

• Anderson, H., Crowther, D., Deakin, D., Ryder, W. & Radford, J (1991). A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-year follow-up. Ann Oncol, 2 Suppl 2, 49-54. eScholarID:144679 | PMID:2049321
• Anderson, H., Prendiville, J., Thatcher, N., Radford, J. & Swindell, R (1991). A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer. J Cancer Res Clin Oncol, 117 Suppl 4, S139-40. eScholarID:144683 | PMID:1665490
• Banerjee, S., Harris, M., Eyden, B., Radford, J., Harrison, C. & Mainwaring, A (1991). Monocytoid B cell lymphoma. J Clin Pathol, 44(1), 39-44. eScholarID:144693 | PMID:1997532
• Prendiville, J., Radford, J., Thatcher, N., Steward, W., Ranson, M., Burt, P. & Stout, R (1991). Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy. J Clin Oncol, 9(8), 1446-52. eScholarID:144758 | PMID:1649266
• Radford, J. & Crowther, D (1991). Treatment of relapsed Hodgkin's disease using a weekly chemotherapy of short duration: results of a pilot study in 20 patients. Ann Oncol, 2(7), 505-9. eScholarID:144710 | PMID:1911458
• Radford, J., Margison, J., Swindell, R., Lind, M., Wilkinson, P. & Thatcher, N (1991). The stability of ifosfamide in aqueous solution and its suitability for continuous 7-day infusion by ambulatory pump. J Cancer Res Clin Oncol, 117 Suppl 4, S154-6. eScholarID:144714 | PMID:1795005
• Ranson, M., Radford, J., Swindell, R., Deakin, D., Wilkinson, P., Harris, M., Johnson, R. & Crowther, D (1991). An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP. Ann Oncol, 2(6), 423-9. eScholarID:144687 | PMID:1768629

1990

• Coutinho, L., Will, A., Radford, J., Schiró, R., Testa, N. & Dexter, T (1990). Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture. Blood, 75(11), 2118-29. eScholarID:144757 | PMID:1693295
• Radford, J., Testa, N. & Crowther, D (1990). The long-term effects of MVPP chemotherapy for Hodgkin's disease on bone marrow function. Br J Cancer, 62(1), 127-32. eScholarID:144706 | PMID:2390472
• Steward, W., Scarffe, J., Dirix, L., Chang, J., Radford, J., Bonnem, E. & Crowther, D (1990). Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer. Br J Cancer, 61(5), 749-54. eScholarID:144695 | PMID:1692472

1989

• Borg-Grech, A., Radford, J., Crowther, D., Swindell, R. & Harris, M (1989). A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease. J Clin Oncol, 7(9), 1303-9. eScholarID:144680 | PMID:2769329
• Cowan, R., Jones, M., Harris, M., Steward, W., Radford, J., Wagstaff, J., Deakin, D. & Crowther, D (1989). Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma. Br J Cancer, 59(2), 276-82. eScholarID:144701 | PMID:2930692

1988

• Radford J.A., Thatcher N. (1988). The toxicity of cancer chemotherapy in adults. Cancer Care, 5, 4-7. eScholarID:144811
• Radford, J., Cowan, R., Flanagan, M., Dunn, G., Crowther, D., Johnson, R. & Eddleston, B (1988). The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol, 6(6), 940-6. eScholarID:144709 | PMID:3373265

1985

• Radford, J., Knight, R. & Rubens, R (1985). Mitomycin C and vinblastine in the treatment of advanced breast cancer. Eur J Cancer Clin Oncol, 21(12), 1475-7. eScholarID:144692 | PMID:3938396

1983

• MacDonald, B., Jones, P., Russell, R., Radford, J. & Martin, J (1983). Urinary 6-oxo prostaglandin F1 alpha in myocardial infarction. Br Med J (Clin Res Ed), 287(6394), 727. eScholarID:144752 | PMID:6412799